Keynote224. Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma:  — van laethem jl, et al.

 — as you probably already know, dr. Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (hcc):